Australia markets open in 4 hours 24 minutes

Atomo Diagnostics Limited (AT1.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.0280-0.0020 (-6.67%)
At close: 04:10PM AEST

Atomo Diagnostics Limited

3-5 George Street
Level 1
Leichhardt, NSW 2040
61 2 9099 4750

IndustryMedical Devices
Full-time employees

Key executives

NameTitlePayExercisedYear born
Mr. John Michael KellyFounder, CEO, MD & Director527.16kN/AN/A
Ms. Chandra SukumarChief Operating Officer324.29kN/AN/A
Mr. Jim P. McMenamyHead of Business Development & Partnerships of the AmericasN/AN/AN/A
Ms. Anna TuckerHead of Business Development & Partnerships of Europe, Middle East and AfricaN/AN/AN/A
Ms. Maria ClementeCompany SecretaryN/AN/AN/A
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.


Atomo Diagnostics Limited engages in the development and sale of medical devices worldwide. It offers rapid diagnostic test devices for HIV screening, pregnancy test, and respiratory test. Atomo Diagnostics Limited was incorporated in 2010 and is headquartered in Leichhardt, Australia.

Corporate governance

Atomo Diagnostics Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.